Detection of fetal duplication 16p11.2q12.1 by next-generation sequencing of maternal plasma and invasive diagnosis

References

• Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–487.
   PubMed Web of Science ®Google Scholar
• Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62(4):768–775.
   PubMed Web of Science ®Google Scholar
• Dondorp W, de Wert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23(11):1438–1450.
   PubMed Web of Science ®Google Scholar
• Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2015;45(3):249–266.
   PubMed Web of Science ®Google Scholar
• Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol. 2013;42(1):15–33.
   PubMed Web of Science ®Google Scholar
• Benn P. Non-invasive prenatal testing using cell free DNA in maternal plasma: recent developments and future prospects. J Clin Med. 2014;3(2):537–565.
   PubMedGoogle Scholar
• McCarroll SA, Kuruvilla FG, Korn JM, et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet. 2008;40(10):1166–1174.
   PubMed Web of Science ®Google Scholar
• Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet. 2009;18(R1):R1–R8.
   PubMed Web of Science ®Google Scholar
• Lee C, Scherer SW. The clinical context of copy number variation in the human genome. Expert Rev Mol Med. 2010;12:e8.
   PubMed Web of Science ®Google Scholar
• Benn P, Cuckle H. Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma. Prenat Diagn. 2014;34(8):778–783.
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet. 2013;92(2):167–176.
   PubMed Web of Science ®Google Scholar
• Yu SC, Jiang P, Choy KW, et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One. 2013;8(4):e60968.
   PubMed Web of Science ®Google Scholar
• Lau TK, Jiang FM, Stevenson RJ, et al. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn. 2013;33(6):602–608.
   PubMed Web of Science ®Google Scholar
• Chen S, Lau TK, Zhang C, et al. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn. 2013;33(6):584–590.
   PubMed Web of Science ®Google Scholar
• Straver R, Sistermans EA, Holstege H, et al. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res. 2014;42(5):e31.
   PubMed Web of Science ®Google Scholar
• Rampášek L, Arbabi A, Brudno M. Probabilistic method for detecting copy number variation in a fetal genome using maternal plasma sequencing. Bioinformatics. 2014;30(12):i212–i218.
   PubMed Web of Science ®Google Scholar
• Zhao C, Tynan J, Ehrich M, et al. Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. Clin Chem. 2015;61(4):608–616.
   PubMed Web of Science ®Google Scholar
• Korostelev S, Totchiev G, Kanivets I, et al. Association of non-invasive prenatal testing and chromosomal microarray analysis for prenatal diagnostics. Gynecol Endocrinol. 2014;30(Suppl1):13–16.
   Web of Science ®Google Scholar
• Jiang F, Ren J, Chen F, et al. Noninvasive fetal trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics. 2012;5:57.
   PubMed Web of Science ®Google Scholar
• Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn. 2012;32(13):1225–1232.
   PubMed Web of Science ®Google Scholar
• Liao C, Yin AH, Peng CF, et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. Proc Natl Acad Sci USA. 2014;111(20):7415–7420.
   PubMed Web of Science ®Google Scholar
• Barber JC, Zhang S, Friend N, et al. Duplications of proximal 16q flanked by heterochromatin are not euchromatic variants and show no evidence of heterochromatic position effect. Cytogenet Genome Res. 2006;114(3–4):351–358.
   PubMed Web of Science ®Google Scholar
• Barber JC, Brasch-Andersen C, Maloney VK, et al. A novel pseudo-dicentric variant of 16p11.2-q11.2 contains euchromatin from 16p11.2-p11.1 and resembles pathogenic duplications of proximal 16q. Cytogenet Genome Res. 2013;139(1):59–64.
   PubMed Web of Science ®Google Scholar
• Peters D, Chu T, Yatsenko SA, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med. 2011;365(19):1847–1848.
   PubMed Web of Science ®Google Scholar
• Sehnert AJ, Rhees B, Comstock D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem. 2011;57(7):1042–1049.
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119(5):890–901.
   PubMed Web of Science ®Google Scholar
• Taglauer ES, Wilkins-Haug L, Bianchi DW. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta. 2014;35(Suppl):S64–S68.
   PubMed Web of Science ®Google Scholar
• Grati FR, Malvestiti F, Ferreira JC, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014;16(8):620–624.
   PubMed Web of Science ®Google Scholar
• Grömminger S, Yagmur E, Erkan S, et al. Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins. J Clin Med. 2014;3(3):679–692.
   PubMedGoogle Scholar
• Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn. 2013;33(6):609–611.
   PubMed Web of Science ®Google Scholar
• Smeets DF. Historical prospective of human cytogenetics: from microscope to microarray. Clin Biochem. 2004;37(6):439–446.
   PubMed Web of Science ®Google Scholar
• Gijsbers AC, Ruivenkamp CA. Molecular karyotyping: from microscope to SNP arrays. Horm Res Paediatr. 2011;76(3):208–213.
   PubMed Web of Science ®Google Scholar
• Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008;358(7):667–675.
   PubMed Web of Science ®Google Scholar
• Kirov G. The role of copy number variation in schizophrenia. Expert Rev Neurother. 2010;10(1):25–32.
   PubMed Web of Science ®Google Scholar
• Barber JC, Hall V, Maloney VK, et al. 16p11.2-p12.2 duplication syndrome; a genomic condition differentiated from euchromatic variation of 16p11.2. Eur J Hum Genet. 2013;21(2):182–189.
   PubMed Web of Science ®Google Scholar